PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Asthma drug Zileuton blocks food allergy reactions in mice

Study finds new biological trigger for anaphylaxis — and a drug that worked ‘shockingly well’ to stop it

2025-08-07
(Press-News.org) Scientists blocked a newly discovered anaphylaxis pathway in mice using Zileuton Mice went from 95% susceptible to anaphylaxis to 95% protected ‘A totally different, out-of-the-box approach to treat food allergy’ Clinical trial recently launched to test the same approach in humans CHICAGO --- A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in mice — a breakthrough that could lead to new protection for millions of people living with food allergies, reports a new Northwestern Medicine study.

The findings will be published August 7 in the journal Science.

The discovery came after the Northwestern scientists identified, in mice, a previously unknown role for a gene called DPEP1, which they found is essential in regulating anaphylaxis, a rapid and potentially fatal allergic reaction.

By using the asthma drug Zileuton to block the pathway involving this gene, the scientists nearly eliminated allergic responses in mice that were previously highly susceptible to food-induced anaphylaxis. The mice were given peanut extract orally shortly after receiving Zileuton while the team monitored for symptoms.

“It was actually shocking how well Zileuton worked,” said co-senior study author Dr. Stephanie Eisenbarth, the director of the Center for Human Immunobiology and chief of the Division of Allergy and Immunology at Northwestern University Feinberg School of Medicine.

“After treatment with Zileuton, 95% of the mice showed almost no symptoms of anaphylaxis. The treatment reversed their risk from 95% susceptible to 95% protected,” added co-senior author Dr. Adam Williams, an associate professor of medicine (allergy and immunology) at Feinberg.

The discovery of the new pathway came after a yearslong forward genetic screen, a process where scientists breed generations of mice to narrow down the specific genes responsible for biological differences, such as susceptibility to food allergy. Once the scientists found that the DPEP1 gene controlled leukotrienes in the gut — inflammatory molecules already targeted by asthma drugs — they tested Zileuton, an FDA-approved drug that blocks their production.

‘Out-of-the-box approach to treat food allergy’

Food allergies are on the rise and affect more than 33 million people in the U.S. — nearly one in 10 people. Yet predicting an allergic individual’s risk of anaphylaxis and preventing severe reactions from accidental exposure remains challenging.

Currently, there are only two FDA-approved treatments for certain food allergies — and no cure. One is an oral immunotherapy for peanut allergy, which doesn’t work for everyone and can itself trigger anaphylaxis. The other is a costly injection (omalizumab) that also isn’t effective for all allergic patients.

Zileuton could offer a new approach: a simple pill that temporarily shields allergic individuals by blocking the body’s anaphylactic pathway before it activates.

“This is a totally different, out-of-the-box approach to treat food allergy, unlike anything we’ve tried before,” Williams said. “We’ve seen tragic, even fatal reactions from hidden ingredients like ground peanuts in a sauce. For parents sending their child to a birthday party, or for anyone flying where they can’t control what’s being served, this could be a powerful protective drug.”

The Northwestern team launched a small early-stage clinical trial in July to test whether blocking this newly identified pathway with Zileuton in humans is as effective as it was in mice.

Helping to solve a food allergy mystery

The findings also shed light on a long-standing puzzle in allergy medicine: why some individuals test positive for food allergens but experience no symptoms when they eat the food.

“Let’s say you’re told you’re allergic to peanuts based on a blood test, but you’ve eaten peanuts your whole life without any problems,” Eisenbarth said. “This pathway we discovered may be one explanation for why some of those people are protected.”

That group has been a challenge for clinicians and a source of stress for patients, Eisenbarth added, because current diagnostic tests only estimate allergy risk, not tolerance.

“Our findings open a whole new area for future research into how people develop food allergies in the first place, and why some react while others don’t,” she said.

The breakthrough wouldn’t have been possible without long-term investment in scientific research, Eisenbarth said.

“If you’d asked me five or six years ago to guess the pathway that would lead to this discovery, I never would have picked this gene or the leukotriene molecules,” she said.

The other Northwestern University authors that supported the study are Danielle Jacobsen, Dr. Eli Olson, Dr. Slim Fourati, Dr. Aditi Verma, Caleb McBride, Kara Greenfield and Rebecca Krier-Burris. The work was done in collaboration with investigators across the U.S. including Laura Hoyt, Emily Siniscalco, Dr. Elise Liu, and Dr. Craig Wilen from Yale University.

This study titled, “Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice,” was funded the by Ira & Diana Riklis Family Research Award in Food Allergy, The Food Allergy Science Initiative Inc, The Food Allergy Fund, the National Institute of Allergy and Infectious Diseases (grants R01 AI136942, R01 AI168016, R56 AI155497 U19AI136053) and the National Institute of Health (grant P50 CA236733.)

The paper will appear in the same issue of Science with another study, led by Dr. Ruslan Medzhitov at Yale University, that also discovered the leukotriene pathway that regulates food allergy in mice through a different approach.

END


ELSE PRESS RELEASES FROM THIS DATE:

Molecules in the spotlight: Snapshots reveal the eternal dance of particles

2025-08-07
FRANKFURT. Most of us find it difficult to grasp the quantum world: According to Heisenberg’s uncertainty principle, it’s like observing a dance without being able to see simultaneously exactly where someone is dancing and how fast they’re moving – you always must choose to focus on one. And yet, this quantum dance is far from chaotic; the dancers follow a strict choreography. In molecules, this strange behavior has another consequence: Even if a molecule should be completely frozen at absolute zero, it never truly comes to rest. The atoms it is made of perform a constant, never-ending quiet dance driven by so-called ...

What drives anaphylactic response in food allergies

2025-08-07
New research in mice reveals that food-induced anaphylaxis is driven by distinct immune pathways involving inflammatory lipids called leukotrienes. The findings, published across two separate studies, identify genetic and cellular factors that influence susceptibility to severe allergic reactions and point to the potential of the drug Zileuton to block this life-threatening response. Food allergies arise when the immune system mounts an exaggerated response to certain proteins found in foods. This reaction is typically driven by Immunoglobulin E (IgE) antibodies, which recognize dietary allergens and activates mast cells throughout the body. In severe ...

A thoughtful approach to governing emerging quantum technologies

2025-08-07
In a Policy Forum, Mateo Aboy and colleagues argue that, instead of turning immediately to rigid regulation to govern emerging quantum technologies, the community should apply a standards-based governance approach tailored to the early, technically focused stage of development. Quantum technologies are poised to revolutionize everything from computing to medicine, offering performance leaps that far surpass the limits of current systems. Yet, this promise comes with complex governance challenges, as these powerful tools ...

What makes the teeth of chitons iron hard?

2025-08-07
A group of marine mollusks called chitons produce extraordinarily tough teeth, which they use to scrape algae off rocks for food. Now, researchers report the protein RTMP1 (radular teeth matrix protein 1) appears to guide the precise formation of the iron-based mineral magnetite in the ultra-hard teeth of chitons. The findings mark the first known instance of an iron oxide-forming protein in a eukaryote, offering new insights into biomineralization and potential inspiration for novel materials design. Throughout the animal kingdom, many organisms ...

New antibody targeting approach, tested in mice, improves distribution and safety of Alzheimer’s immunotherapies

2025-08-07
A newly engineered antibody transport vehicle targeting the transferrin receptor enables enhanced delivery of anti-amyloid antibodies to the brains of mouse models of Alzheimer’s disease, researchers report. According to the study, the approach preserves key immune functions, such as microglial clearance of plaques, while offering a safer and more effective delivery strategy for anti–amyloid immunotherapies. Alzheimer’s disease (AD) is marked by the buildup of amyloid-β (Aβ) protein plaques in the brain. ...

UC Irvine scientist takes a lesson from ultrahard, wear-resistant mollusk teeth

2025-08-07
  Irvine, Calif. — Researchers at the University of California, Irvine and Japan’s Okayama and Toho universities conducted a first-of-its-kind study to understand how chitons, mollusks that feed on algae growing on intertidal rocks, develop such hard, wear-resistant and magnetic teeth, and what they learned is inspiring new ways to produce advanced materials for a variety of applications. The results were published today in Science. In its study, the team unveiled the process by which chiton-specific, iron-binding ...

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials

2025-08-07
The ability to detect single photons (the smallest energy packets constituting electromagnetic radiation) in the infrared range has become a pressing need across numerous fields, from medical imaging and astrophysics to emerging quantum technologies. In observational astronomy, for example, the light from distant celestial objects can be extremely faint and require exceptional sensitivity in the mid-infrared. Similarly, in free-space quantum communication—where single photons need to travel across vast distances—operating in ...

New scaffold technology helps combat traumatic brain injury by restoring copper balance

2025-08-07
Traumatic brain injury (TBI) remains one of the leading causes of disability worldwide. Recent research has developed a novel electrospun scaffold loaded with copper oxide (CuO@PG), which aims to restore copper homeostasis and modulate inflammation in TBI. The study shows that CuO@PG scaffolds significantly reduce neuronal pyroptosis (a form of programmed cell death), alleviate brain swelling, and improve motor and cognitive functions in animal models. These findings provide a promising therapeutic approach to mitigate the neurodegenerative effects ...

Bone metastases cultivate immature immune cells to resist immunotherapy

2025-08-07
AUGUST 7, 2025, NEW YORK – Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone metastases are often debilitating, even deadly. They are also notoriously resistant to all kinds of treatment, including immunotherapy. Now a Ludwig Cancer Research study has identified in the microenvironment of bone tumors a key architect of that resistance. Researchers co-led by Taha Merghoub and Tao Shi of the Ludwig Collaborative Laboratory at Weill Cornell Medicine with colleagues at Nanjing ...

Liming can help enhance carbon capture in agricultural fields

2025-08-07
Adding crushed calcium carbonate — limestone — to agricultural fields can remove tons of carbon dioxide from the atmosphere each year while improving crop yields, a Yale-led study published in Nature Water found. Greenhouse gases in the atmosphere hit a record high in 2024 reaching over 420 parts per million. The U.N. Intergovernmental Panel on Climate Change (IPCC) has identified carbon removal as one key tool in limiting warming to 1.5 C above pre-industrial levels to help mitigate climate change. To reach that target, 15 billion tons of carbon would have to be removed from the atmosphere each year. “There ...

LAST 30 PRESS RELEASES:

Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients

UVic research predicts worldwide glacier erosion

A new boost for CryoZoo, Barcelona’s animal cell biobank

Asthma drug Zileuton blocks food allergy reactions in mice

Molecules in the spotlight: Snapshots reveal the eternal dance of particles

What drives anaphylactic response in food allergies

A thoughtful approach to governing emerging quantum technologies

What makes the teeth of chitons iron hard?

New antibody targeting approach, tested in mice, improves distribution and safety of Alzheimer’s immunotherapies

UC Irvine scientist takes a lesson from ultrahard, wear-resistant mollusk teeth

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials

New scaffold technology helps combat traumatic brain injury by restoring copper balance

Bone metastases cultivate immature immune cells to resist immunotherapy

Liming can help enhance carbon capture in agricultural fields

National study urges expanded vaccine screening in emergency departments

Simple color-changing sensor quickly identifies poisonous gases

Exosomes found to play a double role in tumor growth and immune response

Announcing Gordian Biotechnology as Tier 5 Sponsor of ARDD 2025

Disconnection between brain regions explains why some people don’t enjoy music

An interstellar mission to a black hole? Astrophysicist thinks it’s possible.

Earth’s natural CO2 vacuum cleaners

It's not all about size

Cost-effectiveness of 2023-2024 COVID-19 vaccination in US adults

Demographics, lifestyle, comorbidities, prediabetes, and mortality

Climate change: Perito Moreno Glacier retreat has recently accelerated substantially

Population history of the Southern Caucasus

Biomarkers reveal risk of cardiovascular disease in type 2 diabetes

UVA harnesses AI to improve brain cancer care

MIT imaging tech promises deepest looks yet into living brain tissue at single-cell resolution

City of Hope Research Spotlight, July 2025

[Press-News.org] Asthma drug Zileuton blocks food allergy reactions in mice
Study finds new biological trigger for anaphylaxis — and a drug that worked ‘shockingly well’ to stop it